April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Sustained and Observable Release of Daunorubicin/Doxorubicin Using Porous Si Particles: A Potential Treatment for Proliferative Vitreo-Retinopathy
Author Affiliations & Notes
  • E. C. Wu
    UC San Diego, La Jolla, California
  • J. Park
    Materials Science and Engineering,
    UC San Diego, La Jolla, California
  • L. Cheng
    Shiley Eye Center, La Jolla, California
  • W. R. Freeman
    Shiley Eye Center, La Jolla, California
  • M. J. Sailor
    Chemistry and Biochemistry,
    UC San Diego, La Jolla, California
  • Footnotes
    Commercial Relationships  E.C. Wu, None; J. Park, None; L. Cheng, None; W.R. Freeman, None; M.J. Sailor, None.
  • Footnotes
    Support  NIH U54-CA-119335
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5965. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. C. Wu, J. Park, L. Cheng, W. R. Freeman, M. J. Sailor; Sustained and Observable Release of Daunorubicin/Doxorubicin Using Porous Si Particles: A Potential Treatment for Proliferative Vitreo-Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5965.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : There is an unmet need for a minimally invasive controlled and observable drug delivery system, enabling long acting local treatment of intraocular diseases. To address challenges in the delivery of drugs with narrow therapeutic indices, we have developed biodegradable and biocompatible porous Si micoparticles with tunable photonic properties. The particles can be loaded with daunorubicin (DNR) and doxorubicin (DOX) through covalent attachment, allowing a slow release of the drugs. The optical properties can be used to monitor release of the drugs in the vitreous.

Methods: : Porous Si particles were prepared by the electrochemical etching of Si wafers and were subsequently functionalized with DNR or DOX using a covalent linkage. The porous structure of the particles gives rise to an optical reflectance spectrum, which can be tuned by varying the etching conditions. As drugs are loaded in or released from the pores the optical reflectance spectrum changes, resulting in a color shift. In vitro drug release was characterized using fluorescence spectroscopy.

Results: : Optical spectra of DOX loaded particles were monitored over a period of 7 days and the amount of drug released was quantified. ~15% of the loaded drug was released during this period. The spectra of the particles shifted ~80 nm.

Conclusions: : DNR and DOX can be loaded into porous Si particles via covalent attachment and are slowly released as the porous Si matrix degrades. The unique optical properties of porous Si allow for a simple method of monitoring the extent of release in a clinical non-invasive setting after intravitreal injection. Preliminary release data suggests that drug release can be tuned to occur over a period of months and that it is monitorable by an ophthalmoscope or fundus camera.

Keywords: retina • vitreous • retinal detachment 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.